Neurosense Therapeutics Ltd (NRSN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NRSN | AZN | AMGN | GILD | VRTX |
| Company | Neurosense Therapeutics Ltd | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 1.0700 | 90.36 | 329.09 | 120.98 | 455.65 |
| High | 1.0999 | 91.36 | 329.67 | 122.37 | 457.17 |
| Low | 0.9500 | 89.67 | 320.17 | 120.54 | 439.80 |
| Latest | 0.9900 | 91.28 | 321.23 | 121.19 | 442.04 |
| Change | -0.1800 | +1.10 | -8.66 | -0.03 | -13.44 |
| % Change | -15.38% | +1.22% | -2.63% | -0.02% | -2.95% |
| Volume | 820,000 | 7,055,400 | 3,510,700 | 8,870,600 | 1,504,500 |
| 20-Day Average Volume | 420,405 | 5,597,605 | 2,926,110 | 7,137,915 | 1,421,030 |
| Previous Close | 1.1700 | 90.18 | 329.89 | 121.22 | 455.48 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.0823 | 90.17 | 337.54 | 124.47 | 434.61 |
| 20-Day Raw Stochastic | 25.73% | 66.52% | 6.30% | 35.09% | 59.12% |
| 20-Day Relative Strength | 43.63 | 61.80 | 49.28 | 48.08 | 56.05 |
| Weighted Alpha | +1.45 | +40.91 | +19.36 | +28.92 | -1.47 |
| Today's Opinion | 96% Sell | 100% Buy | 80% Buy | 80% Buy | 24% Buy |
| Previous Opinion | 56% Sell | 100% Buy | 80% Buy | 80% Buy | 40% Buy |
| Last Month's Opinion | 88% Sell | 100% Buy | 56% Buy | 100% Buy | 56% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -15.38% since 12/01/25 | +0.84% since 12/01/25 | -4.82% since 12/01/25 | -2.53% since 12/01/25 | +3.86% since 12/01/25 |
| Low | 0.9500 on 12/08/25 | 89.67 on 12/08/25 | 320.17 on 12/08/25 | 120.38 on 12/05/25 | 424.06 on 12/02/25 |
| High | 1.2400 on 12/04/25 | 91.36 on 12/08/25 | 346.38 on 12/03/25 | 125.60 on 12/03/25 | 463.85 on 12/03/25 |
| 1-Month | |||||
| %Chg | +6.45% since 11/07/25 | +7.92% since 11/07/25 | +0.32% since 11/07/25 | +1.98% since 11/07/25 | +7.95% since 11/07/25 |
| Low | 0.8930 on 11/13/25 | 85.85 on 11/10/25 | 319.54 on 11/10/25 | 117.13 on 11/10/25 | 410.50 on 11/10/25 |
| High | 1.2700 on 11/19/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 3-Month | |||||
| %Chg | -14.66% since 09/08/25 | +11.92% since 09/08/25 | +14.65% since 09/08/25 | +4.58% since 09/08/25 | +11.84% since 09/08/25 |
| Low | 0.8930 on 11/13/25 | 72.89 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 374.17 on 09/24/25 |
| High | 1.9800 on 09/10/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 6-Month | |||||
| %Chg | -44.69% since 06/06/25 | +25.25% since 06/06/25 | +10.64% since 06/06/25 | +7.76% since 06/06/25 | -1.88% since 06/06/25 |
| Low | 0.8930 on 11/13/25 | 68.61 on 07/21/25 | 267.83 on 06/23/25 | 104.46 on 06/25/25 | 362.50 on 08/11/25 |
| High | 2.6000 on 06/12/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 484.56 on 07/10/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 13,533 | 283,098,176 | 172,976,256 | 150,358,016 | 112,153,952 |
| Shares Outstanding, K | 13,670 | 3,101,426 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 0 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -10,210,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 0 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | -1,800,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | 1.58 | 0.31 | 0.45 | 0.32 | 0.32 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.06 on 04/07/25 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 12/17/25 | 11/06/25 | 11/04/25 | 10/30/25 | 11/03/25 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 09/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 08/08/25 | 11/21/25 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.73 | 15.08 | 14.80 | 29.75 |